INOZYME PHARMA, INC. Debt Issuance Costs, Noncurrent, Net
INOZYME PHARMA, INC. had Debt Issuance Costs, Noncurrent, Net of $2.65 million as of 2020-06-30, per its 10-Q filed 2020-09-03.
Discontinued › Notes
us-gaap:DeferredFinanceCostsNoncurrentNet · last filed 2021-03-25
- 2020-06-30: Debt Issuance Costs, Noncurrent, Net $2.65M.
- 2019-12-31: Debt Issuance Costs, Noncurrent, Net $56.00K.
| Period end | Debt Issuance Costs, Noncurrent, Net |
|---|---|
| 2020-06-30 | $2.65M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $56.00K 10-K · filed 2021-03-25 |